Publikationen von M. Uhr

Dzaja, A. E.; Schuld, A.; Uhr, M.; Pollmächer, T.: Influence of sleep deprivation on plasma ghrelin levels in healthy subjects. Sleep 26, S. A177 - A177 (2003)

Steiger, A.; Weikel, J. C.; Wichniak, A.; Ising, M.; Brunner, H.; Friess, E.; Held, K.; Mathias, S.; Schmid, D. A.; Uhr, M.: Ghrelin promotes slow-wave sleep in man. Biological Psychiatry 53 (8 Suppl.), S. 209S - 209S (2003)

Bschor, T.; Baethge, C.; Adli, M.; Eichmann, U.; Ising, M.; Uhr, M.; Modell, S.; Künzel, H.; Müller-Oerlinghausen, B.; Bauer, M.: Association between response to lithium augmentation and the combined DEX/CRH test in major depressive disorder. Journal of Psychiatric Research 37 (2), S. 135 - 143 (2003)

Steiger, A.; Schmid, D. A.; Ising, M.; Uhr, M.; Weikel, J. C.; Held, K.: Opposite changes of nocturnal ghrelin and leptin levels during treatment of depression with mirtazapine. Naunyn-Schmiedebergs Archives of Pharmacology 367 (Suppl. Suppl. 1), S. R111 - R111 (2003)

Keck, M. E.; Welt, T.; Müller, M. B.; Uhr, M.; Ohl, F.; Wigger, A.; Toschi, N.; Holsboer, F.; Landgraf, R.: Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevate behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model. Neuropsychopharmacology 28 (2), S. 235 - 243 (2003)

Antonijevic, I. A.; Murck, H.; Frieboes, R.-M.; Uhr, M.: On the role of menopause for sleep-endocrine alterations associated with major depression. Psychoneuroendocrinology 28, S. 401 - 418 (2003)

Bschor, T.; Baethge, C.; Adli, M.; Eichmann, U.; Ising, M.; Uhr, M.; Müller-Oerlinghausen, B.; Bauer, M.: Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression. Depression and Anxiety 17 (1), S. 43 - 48 (2003)

Deuschle, M.; Lecei, O.; Stalla, G. K.; Landgraf, R.; Hamann, B.; Lederbogen, F.; Uhr, M.; Luppa, P.; Maras, A.; Colla, M. et al.; Heuser, I.: Steroid synthesis inhibition with ketoconazole and its effects upon the regulation of the hypothalamus-pituitary-adrenal system in healthy humans. Neuropsychopharmacology 28 (2), S. 379 - 383 (2003)

Müller, M. B.; Keck, M. E.; Binder, E. B.; Kresse, A. E.; Hagemeyer, T. P.; Landgraf, R.; Holsboer, F.; Uhr, M.: ABCBI (MDRI)- type P-Glycoproteins at the blood-brain barrier modulate the activity of the hypothalamic-pituitary-adrenocortical system: implications for affective disorder. Neuropsychopharmacology 28 (11), S. 1991 - 1999 (2003)

Uhr, M.; Grauer, M. T.: abcb1ab P-glycoprotein is involved in the uptake of citalopram and trimipramine into the brain of mice. Journal of Psychiatric Research 37 (3), S. 179 - 185 (2003)

Uhr, M.; Grauer, M. T.; Holsboer, F.: Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) p-glycoprotein gene disruption. Biological Psychiatry 54 (8), S. 840 - 846 (2003)

Binder, E. B.; Lichtner, P.; Bettecken, T.; Strom, T.; Uhr, M.; Meitinger, T.; Modell, S.; Holsboer, F.: Mutation analysis of genes regulating the hypothalamo-pituitary adrenal (HPA) axis in patients with depressive syndrome. American Journal of Medical Genetics 114 (7), S. 752 - 753 (2002)

Binder, E. B.; Lichtner, P.; Uhr, M.; Bettecken, T.; Strom, T. M.; Meitinger, T.; Modell, S.; Holsboer, F.: Mutation analysis of genes regulating the hypothalamo-pituitary adrenal (HPA) axis in patients with depressive syndrome. American Journal of Human Genetics 71 (4 Suppl. Suppl. S), S. 468 - 468 (2002)

Dalal, M. A.; Schuld, A.; Haack, M.; Uhr, M.; Geisler, P.; Eisensehr, I.; Noachtar, S.; Pollmächer, T.: Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients. Neurology 56, S. 1749 - 1751 (2001)

Uhr, M.: Multiple Sklerose. Liquoranalyse in der MS-Diagnostik. Neurotransmitter 3, S. 59 - 60 (2001)

Zobel, A. W.; Nickel, T.; Sonntag, A.; Uhr, M.; Holsboer, F.; Ising, M.: Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression: a prospective study. Journal of Psychiatric Research 35, S. 83 - 94 (2001)

Post, A.; Crochemore, C.; Uhr, M.; Holsboer, F.; Behl, C.: Differential induction of NF-κB activity and neural cell death by antidepressants in vitro. European Journal of Neuroscience 12, S. 4331 - 4337 (2000)

Schuld, A.; Blum, W. F.; Uhr, M.; Haack, M.; Kraus, T.; Holsboer, F.; Pollmächer, T.: Reduced leptin levels in human narcolepsy. Neuroendocrinology 72, S. 195 - 198 (2000)

Uhr, M.; Steckler, T.; Yassouridis, A.; Holsboer, F.: Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to Mdr 1 a p-glycoprotein gene disruption. Neuropsychopharmacology 22, S. 380 - 387 (2000)

Kraus, T.; Haack, M.; Schuld, A.; Hinze-Selch, D.; Kühn, M.; Uhr, M.; Pollmächer, T.: Body weight and leptin plasma levels during treatment with antipsychotic drugs. American Journal of Psychiatry 156, S. 312 - 314 (1999)